6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: a putative mechanism for corticoid-induced osteoporosis
Tóm tắt
Osteoclasts are large, multinucleated cells, which originate from the fusion of macrophages. They play a central role in bone development and remodeling via the resorption of bone and are thus important mediators of bone loss, which leads to osteoporosis. IL-1R-associated kinase (IRAK)-M is a pseudokinase, which acts as a negative modulator of innate immune responses mediated by TLRs and IL-1R. Recently, it has been reported that IRAK-M also participates in the control of macrophage differentiation into osteoclasts. In addition, it was shown that IRAK-M knockout mice develop a strong osteoporosis phenotype, suggesting that down-regulation of this molecule activates osteoclast-mediated bone resorption. We studied the effect of the osteoporosis-inducing glucocorticoid, 6-methylprednisolone (6-MP), on IRAK-M expression in osteoclasts. Our results showed that osteoclasts, derived from THP-1 and RAW cells as well as human blood monocytes, differentiated into osteoclasts, express high levels of IRAK-M at mRNA and protein levels. In addition, 6-MP down-regulates IRAK-M expression, which correlates with an increased activation of bone resorption. These findings suggest a mechanism of corticosteroid-induced osteoporosis and open new avenues for treating this endemic disease of Western societies.
Từ khóa
Tài liệu tham khảo
Li, 2005, IL-1 receptor-associated kinase M is a central regulator of osteoclast differentiation and activation, J. Exp. Med., 201, 1169, 10.1084/jem.20041444
Cappellen, 2002, Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFκB, J. Biol. Chem., 277, 21971, 10.1074/jbc.M200434200
Huang, 2006, Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-κB transactivation by RANKL, Cell Death Differ., 13, 1879, 10.1038/sj.cdd.4401882
Chen, 2004, Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment, Bone, 35, 83, 10.1016/j.bone.2004.03.019
Halloran, 2002, Changes in bone structure and mass with advancing age in the male C57BL/6J mouse, J. Bone Miner. Res., 17, 1044, 10.1359/jbmr.2002.17.6.1044
Susa, 2004, Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay, J. Transl. Med., 2, 6, 10.1186/1479-5876-2-6
Dempster, 1997, Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis, J. Endocrinol., 154, 397, 10.1677/joe.0.1540397
Iwamoto, 2005, Prevention and treatment of corticosteroid-induced osteoporosis, Yonsei Med. J., 46, 456, 10.3349/ymj.2005.46.4.456
Leclerc, 2004, Gene expression profiling of glucocorticoid-inhibited osteoblasts, J. Mol. Endocrinol., 33, 175, 10.1677/jme.0.0330175
Sivagurunathan, 2005, Influence of glucocorticoids on human osteoclast generation and activity, J. Bone Miner. Res., 20, 390, 10.1359/JBMR.041233
Sato, 2006, Osteoclasts, rheumatoid arthritis, and osteoimmunology, Curr. Opin. Rheumatol., 18, 419, 10.1097/01.bor.0000231912.24740.a5
Avnet, 2006, Effects of antisense mediated inhibition of cathepsin K on human osteoclasts obtained from peripheral blood, J. Orthop. Res., 24, 1699, 10.1002/jor.20209
Schell, 2006, Osteoclastic activity begins early and increases over the course of bone healing, Bone, 38, 547, 10.1016/j.bone.2005.09.018
Vignery, 2005, Macrophage fusion: the making of osteoclasts and giant cells, J. Exp. Med., 202, 337, 10.1084/jem.20051123
Rousselle, 2002, Osteoclastic acidification pathways during bone resorption, Bone, 30, 533, 10.1016/S8756-3282(02)00672-5
Del Fresno, 2005, Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4, J. Immunol., 174, 3032, 10.4049/jimmunol.174.5.3032
Del Fresno, 2004, Nitric oxide activates the expression of IRAK-M via the release of TNF-α in human monocytes, Nitric Oxide, 10, 213, 10.1016/j.niox.2004.04.007
Escoll, 2003, Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patient, Biochem. Biophys. Res. Commun., 311, 465, 10.1016/j.bbrc.2003.10.019
Lopez-Collazo, 2006, Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state, Curr. Opin. Infect. Dis., 19, 237, 10.1097/01.qco.0000224817.35105.7d
González-León, 2006, Nitric oxide induces SOCS-1 expression in human monocytes in a TNF-α dependent manner, J. Endotoxin Res., 12, 296, 10.1177/09680519060120050501
Del Fresno, 2006, Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes, J. Endotoxin Res., 13, 39, 10.1177/0968051907078623
Dauphinee, 2006, Lipopolysaccharide signaling in endothelial cells, Lab. Invest., 86, 9, 10.1038/labinvest.3700366
Van Staa, 2002, The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis, Osteoporos. Int., 13, 777, 10.1007/s001980200108
Van Staa, 2003, Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy, Arthritis Rheum., 48, 3224, 10.1002/art.11283
Canalis, 2003, Mechanisms of glucocorticoid-induced osteoporosis, Curr. Opin. Rheumatol., 15, 454, 10.1097/00002281-200307000-00013
Yu, 2004, CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts, J. Bone Miner. Res., 19, 2065, 10.1359/jbmr.040910
Berneis, 1999, Effects of IGF-I combined with GH on glucocorticoid-induced changes of bone and connective tissue turnover in man, J. Endocrinol., 162, 259, 10.1677/joe.0.1620259
Wang, 2002, Effects of methylprednisolone on bone formation and resorption in rats, Jpn. J. Pharmacol., 90, 236, 10.1254/jjp.90.236
Kondo, 2006, High dose glucocorticoid hampers bone formation and resorption after bone marrow abaltion in rat, Microsc. Res. Tech., 69, 839, 10.1002/jemt.20355
Jakob, 1997, Local estradiol metabolism in osteoblast and osteoclast-like cells, J. Steroid Biochem., 61, 167, 10.1016/S0960-0760(97)80009-X
Nakamura, 2006, Role of steroid administration to reduce inflammation after thoracotomy in a rat surgical stress model, J. Surg. Res., 135, 364, 10.1016/j.jss.2006.04.015
Matveev, 1999, Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages, J. Lipid Res., 40, 1647, 10.1016/S0022-2275(20)33410-6
Fitzgerald, 2000, Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages, J. Immunol., 164, 2692, 10.4049/jimmunol.164.5.2692
Teissier, 2004, Peroxisome proliferator-activated receptor α induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-α activation properties, Circ. Res., 95, 1174, 10.1161/01.RES.0000150594.95988.45
Jia, 2006, Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density, Endocrinology, 147, 5592, 10.1210/en.2006-0459